245 related articles for article (PubMed ID: 26674707)
1. Polymorphism of rs3813034 in Serotonin Transporter Gene SLC6A4 Is Associated With the Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Response in Depressive Disorder: Sequencing Analysis of SLC6A4.
Nonen S; Kato M; Takekita Y; Wakeno M; Sakai S; Serretti A; Kinoshita T
J Clin Psychopharmacol; 2016 Feb; 36(1):27-31. PubMed ID: 26674707
[TBL] [Abstract][Full Text] [Related]
2. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A
J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644
[TBL] [Abstract][Full Text] [Related]
3. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
[TBL] [Abstract][Full Text] [Related]
4. Potential involvement of NET polymorphism in serotonin/norepinephrine reuptake inhibitor response in panic disorder.
Park HJ; Kim SK; Kang WS; Kim YJ; Cho AR; Park JK
Nord J Psychiatry; 2016; 70(4):314-7. PubMed ID: 26508020
[TBL] [Abstract][Full Text] [Related]
5. Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample.
Kraft JB; Peters EJ; Slager SL; Jenkins GD; Reinalda MS; McGrath PJ; Hamilton SP
Biol Psychiatry; 2007 Mar; 61(6):734-42. PubMed ID: 17123473
[TBL] [Abstract][Full Text] [Related]
6. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of patients with major depressive disorder switching SSRI/SNRI therapy compared with those augmenting with an atypical antipsychotic in a real-world setting.
Kern DM; Cepeda MS; Castilla-Puentes RC; Savitz A; Etropolski M
Curr Med Res Opin; 2021 Aug; 37(8):1377-1384. PubMed ID: 33818238
[TBL] [Abstract][Full Text] [Related]
8. Influence and interaction of genetic, cognitive, neuroendocrine and personalistic markers to antidepressant response in Chinese patients with major depression.
Bi Y; Ren D; Guo Z; Ma G; Xu F; Chen Z; An L; Zhang N; Ji L; Yuan F; Liu L; Hou B; Yang F; Yu S; Yi Z; Xu Y; He L; Sun X; Dong Z; Wu S; Zhao L; Cai C; Li X; Yu T; Shi Y; He G
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110036. PubMed ID: 32702381
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder.
Yoshimura R; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Katsuki A; Atake K; Nakamura J
Hum Psychopharmacol; 2013 Sep; 28(5):466-70. PubMed ID: 23813968
[TBL] [Abstract][Full Text] [Related]
10. SLC6A4 variation and citalopram response.
Mrazek DA; Rush AJ; Biernacka JM; O'Kane DJ; Cunningham JM; Wieben ED; Schaid DJ; Drews MS; Courson VL; Snyder KA; Black JL; Weinshilboum RM
Am J Med Genet B Neuropsychiatr Genet; 2009 Apr; 150B(3):341-51. PubMed ID: 18618621
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure.
Ahmed AT; Biernacka JM; Jenkins G; Rush AJ; Shinozaki G; Veldic M; Kung S; Bobo WV; Hall-Flavin DK; Weinshilboum RM; Wang L; Frye MA
J Affect Disord; 2019 Mar; 246():62-68. PubMed ID: 30578947
[TBL] [Abstract][Full Text] [Related]
12. Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.
Min W; Li T; Ma X; Li Z; Yu T; Gao D; Zhang B; Yun Y; Sun X
Psychopharmacology (Berl); 2009 Aug; 205(3):409-17. PubMed ID: 19468717
[TBL] [Abstract][Full Text] [Related]
13. Sequence analysis of the serotonin transporter and associations with antidepressant response.
Kraft JB; Slager SL; McGrath PJ; Hamilton SP
Biol Psychiatry; 2005 Sep; 58(5):374-81. PubMed ID: 15993855
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach.
Sreeja V; Jose A; Patel S; Menon B; Athira KV; Chakravarty S
Neurochem Int; 2024 Feb; 173():105672. PubMed ID: 38157886
[TBL] [Abstract][Full Text] [Related]
15. Role of serotonin transporter and receptor gene polymorphisms in treatment response to selective serotonin reuptake inhibitors in major depressive disorder.
Ramesh V; Venkatesan V; Ramasamy B
Hum Psychopharmacol; 2022 Jul; 37(4):e2830. PubMed ID: 34994008
[TBL] [Abstract][Full Text] [Related]
16. Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.
Manoharan A; Shewade DG; Rajkumar RP; Adithan S
Eur J Clin Pharmacol; 2016 Oct; 72(10):1215-1220. PubMed ID: 27439447
[TBL] [Abstract][Full Text] [Related]
17. The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients.
Smits KM; Smits LJ; Peeters FP; Schouten JS; Janssen RG; Smeets HJ; van Os J; Prins MH
Psychiatr Genet; 2008 Aug; 18(4):184-90. PubMed ID: 18628680
[TBL] [Abstract][Full Text] [Related]
18. Clinical risk factors and serotonin transporter gene variants associated with antidepressant-induced mania.
Frye MA; McElroy SL; Prieto ML; Harper KL; Walker DL; Kung S; Chauhan M; Crow S; Sutor B; Galardy CW; Veldic M; Palmer BA; Geske JR; Fuentes M; Cuellar-Barboza AB; Seymour LR; Mori N; Biernacka JM
J Clin Psychiatry; 2015 Feb; 76(2):174-80. PubMed ID: 25611077
[TBL] [Abstract][Full Text] [Related]
19. Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment.
Bauer M; Demyttenaere K; El-Khalili N; Thase ME; Papakostas GI; Szamosi J; Earley WR; Eriksson H
Int Clin Psychopharmacol; 2014 Jan; 29(1):16-25. PubMed ID: 24108148
[TBL] [Abstract][Full Text] [Related]
20. Association between selective serotonin and serotonin-noradrenaline reuptake inhibitor therapy and hematuria.
Sarier M; Demir M; Emek M; Özgen A; Turgut H; Özdemir C
Nord J Psychiatry; 2023 Jan; 77(1):31-35. PubMed ID: 35243962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
